Skip to Content

Bumetanide Tablets

Last Updated: March 4, 2015
Status: Resolved

Products Affected - Description

Bumetanide tablets, Sandoz

0.5 mg tablets, 100 count (NDC 00185-0128-01) 
0.5 mg tablets, 500 count (NDC 00185-0128-05)
1 mg tablets, 100 count (NDC 00185-0129-01)
1 mg tablets, 500 count (NDC 00185-0129-05)
2 mg tablets, 100 count (NDC 00185-0130-01)
2 mg tablets, 500 count (NDC 00185-0130-05)

Reason for the Shortage

  • Mylan Institutional discontinued bumetanide tablets in March 2014.
  • Sandoz cannot provide a reason for the shortage.
  • Teva could not provide a reason for the shortage.

Available Products

Bumetanide tablets, Teva
0.5 mg tablets, 100 count (NDC 00093-4232-01)
mg tablets, 100 count (NDC 00093-4233-01)
1 mg tablets, 1000 count (NDC 00093-4233-10)
2 mg tablets, 100 count (NDC 00093-4234-01)
2 mg tablets, 1000 count (NDC 00093-4234-10)

Estimated Resupply Dates

  • Sandoz has all bumetanide tablet presentations temporarily unavailable and the company cannot estimate a release date.
  • Teva has had all bumetanide tablets available for several weeks.

Updated

March 4, January 21, 2015; December 2, November 4, September 30, August 26, June 4, April 30, March 5, January 27, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide